Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung
Lea Ann Dailey(King's College London), Werner Seeger(Justus-Liebig-Universität Gießen), Thomas Kissel(Helmholtz Zentrum München), Matthias Wittmar(Philipps University of Marburg), N. Jekel(Justus-Liebig-Universität Gießen), Thomas Schmehl(Saarland University), Ludger Fink(Institute of Cytology), Tobias Gessler(University of Giessen)
Cited by 218
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
|The Lancet|2002|771
Pulmonary Hypertension in Chronic Lung Diseases
|Journal of the American College of Cardiology|2013|683